The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Jurrien ten Berg
Showing 1-15 of 15 articles
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial
Zeymer U,
Leiva O,
Hohnloser S,
Steg P,
Oldgren J,
Nickenig G,
Gabor Kiss R,
Ongen Z,
Navarro Estrada J,
Oude Ophuis T,
Lip G,
Nordaby M,
Miede C,
ten Berg J,
Bhatt D,
Cannon C
August 27, 2021 | 10.4244/EIJ-D-20-00799
Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction
Bor W,
Zheng K,
Tavenier A,
Gibson CM,
Granger C,
Bentur O,
Lobatto R,
Postma S,
Coller B,
van ’t Hof A,
ten Berg J
August 6, 2021 | 10.4244/EIJ-D-21-00287
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial
Fabris E,
van't Hof A,
Hamm C,
Lapostolle F,
Lassen J,
Goodman S,
ten Berg J,
Bolognese L,
Cequier A,
Chettibi M,
Hammett C,
Huber K,
Janzon M,
Merkely B,
Storey R,
Zeymer U,
Cantor W,
Rousseau H,
Vicaut E,
Montalescot G
May 15, 2017 | 10.4244/EIJ-D-16-00965
Complete blood flow obstruction due to a distally embolised Edwards SAPIEN valve prosthesis
Nijenhuis V,
Swaans M,
ten Berg J
December 9, 2016 | 10.4244/EIJ-D-16-00064
Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial
Dewilde W,
Janssen P,
Kelder J,
Verheugt F,
de Smet B,
Adrianssens T,
Vrolix M,
Brueren G,
Vandendriessche T,
van Mieghem C,
Cornelis K,
Vos J,
Breet N,
ten Berg J
August 20, 2015 | 10.4244/EIJY14M06_07
Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II)
Teeuwen K,
Van den Branden B,
Rahel B,
Laarman G,
Thijssen J,
Kelder J,
Slagboom T,
ten Berg J,
Suttorp MJ
June 28, 2013 | 10.4244/EIJV9I2A36
A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients
Vranckx P,
Verheugt F,
de Maat MP,
Ulmans V,
Regar E,
Smits P,
ten Berg J,
Lindeboom W,
Jones R,
Friedman J,
Reilly P,
Leebeek F
January 18, 2013 | 10.4244/EIJV8I9A162
Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)
Van den Branden B,
Rahel B,
Laarman G,
Slagboom T,
Kelder J,
ten Berg J,
Suttorp MJ
February 21, 2012 | 10.4244/EIJV7I10A190
Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay
Heestermans A,
de Boer M,
van Werkum J,
Mosterd A,
Gosselink A,
Dambrink J,
van Houwelingen K,
Koopmans P,
Hamm C,
Zijlstra F,
ten Berg J,
van't Hof A
August 30, 2011 | 10.4244/EIJV7I4A73
Comparison of outcome after patent foramen ovale closure in older versus younger patients
Luermans J,
Budts W,
ten Berg J,
Plokker H,
Suttorp MJ,
Post M
June 30, 2011 | 10.4244/EIJV7I2A35
Triggering mechanisms of stent thrombosis
Zwart B,
van Werkum J,
Heestermans A,
Kelder J,
Zomer A,
van't Hof A,
Verheugt F,
ten Berg J
January 20, 2011
Long-term outcome of percutaneous closure of secundum-type atrial septal defects in adults
Luermans J,
Post M,
ten Berg J,
Plokker H,
Suttorp MJ
November 15, 2010
The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety
Van den Branden B,
Luermans J,
Post M,
Plokker H,
ten Berg J,
Suttorp MJ
September 30, 2010
Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial
Timmer J,
ten Berg J,
Heestermans A,
Dill T,
van Werkum J,
Dambrink J,
Suryapranata H,
Ottervanger J,
Hamm C,
van't Hof A
August 15, 2010
Triple therapy: the future or from the past?
Dewilde W,
Breet N,
ten Berg J
January 15, 2010
1
Latest news
AHEAD OF PRINT
In vitro effect of intravascular lithotripsy on the polymer of a drug-eluting stent
FREE ARTICLE - Alexandru Achim et al
July 1, 2022
NEW
EuroIntervention's new Impact Factor!
June 28, 2022
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke